login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
BIORA THERAPEUTICS INC (BIOR) Stock News
USA
-
Nasdaq
- NASDAQ:BIOR -
US74319F3055
-
Common Stock
0.5597
USD
-0.79 (-58.54%)
Last: 12/10/2024, 8:09:45 PM
0.579
USD
+0.02 (+3.45%)
After Hours:
12/10/2024, 8:09:45 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
BIOR Latest News, Press Relases and Analysis
All
Press Releases
8 months ago - By: Biora Therapeutics, Inc.
Biora Therapeutics Successfully Completes Restructuring Process
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics Undertakes Chapter 11 Sale Process to Position Business for Future Growth
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics Undertakes Chapter 11 Sale Process to Position Business for Future Growth
a year ago - By: Benzinga
- Mentions:
PBM
CPIX
CMRX
BSGM
...
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
a year ago - By: Benzinga
Why Biora Therapeutics (BIOR) Stock Is Down 45%
a year ago - By: BusinessInsider
BIOR Stock Earnings: Biora Therapeutics Beats EPS for Q2 2024
a year ago - By: InvestorPlace
BIOR Stock Earnings: Biora Therapeutics Beats EPS for Q2 2024
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics to Reveal 00-Size BioJet™ Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics Achieves ISO 13485 Certification
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics Announces Positive Nasdaq Listing Decision
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics Announces Funding Agreement with Existing Investors
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics Announces Funding Agreement with Existing Investors
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics to Report Second Quarter 2024 Financial Results and Provide Corporate Update
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics to Report Second Quarter 2024 Financial Results and Provide Corporate Update
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics to Participate in Canaccord Genuity 44th Annual Growth Conference
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics Announces Supplemental Data from Phase 1 Clinical Trial of BT-600 as Presented at KOL Event
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics Announces Supplemental Data from Phase 1 Clinical Trial of BT-600 as Presented at KOL Event
a year ago - By: Biora Therapeutics, Inc.
Biora Therapeutics to Host Virtual KOL Event on NaviCap™ Targeted Oral Delivery Platform and Results from Phase 1 Clinical Trial of BT-600 on July 17, 2024
Please enable JavaScript to continue using this application.